Market Maker Surveillance Report. SNV, AMRN, FOSL, SCHW, IPHS, TPIV, Bullishly Biased Price Friction For Tuesday, April 3rd 20
April 3, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 3822 companies with "abnormal" market making, 2169 companies with positive Friction Factors and 3684 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bullish bias) in their stock prices. This means that there was more selling than buying in the stocks and their stock prices rose. Synovus Financial Corp (NYSE:SNV), Amarin Corp PLC (NASDAQ:AMRN), Fossil Inc (NASDAQ:FOSL), SCHWAB (NYSE:SCHW), INNOPHOS HOLDINGS INC (NASDAQ:IPHS), TAPIMMUNE INC (OTCBB:TPIV). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
Market Maker Friction Factor is shown in the chart below:
Symbol Change Percent Buy Volume Buy %% Sell Volume Sell %% Net Volume Friction SNV $0.070 3.40% 2,530,403 22.63% 4,933,238 44.12% -2,402,835 Abnormal AMRN $0.360 3.33% 3,677,549 32.03% 6,662,004 58.02% -2,984,455 Abnormal FOSL $0.590 0.44% 1,246,911 11.22% 9,845,495 88.62% -8,598,584 Abnormal SCHW $0.210 1.44% 7,237,028 28.57% 8,222,263 32.46% -985,235 Abnormal IPHS $0.290 0.58% 446,669 25.71% 1,289,439 74.23% -842,770 Abnormal TPIV $0.015 10.00% 355,521 22.11% 1,252,200 77.89% -896,679 AbnormalAnalysis of the Friction Factor chart above shows that each of the six stocks mentioned above had more selling than buying on Tuesday and their stock prices rose. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.
For example, the chart above shows SNV with 2,402,835 greater shares of selling than buying (NetVol) and the stock price was up $0.07000. This means the Market Makers were trading the stock in a way inconsistent with normal supply and demand (Economics 101); more selling than buying should cause prices to drop.
Synovus Financial Corp (NYSE:SNV) - Synovus Financial Corp., a diversified financial services and bank holding company, provides commercial and retail banking, financial management, insurance, and mortgage services in Georgia, Alabama, South Carolina, Florida, and Tennessee. Its retail banking services include accepting customary types of demand and savings deposits; individual, consumer, installment, and mortgage loans; safe deposit services; automated banking services; automated fund transfers; Internet based banking services; and bank credit card services, including mastercard and visa services, as well as commercial banking services comprise commercial, financial, agricultural, and real estate loans. The company also provides various other financial services, which include the portfolio management for fixed-income securities, investment banking, the execution of securities transactions as a broker/dealer, and the provision of individual investment advice on equity and other securities; trust services; mortgage services; financial planning services; and asset management services. Synovus Financial Corp. was founded in 1888 and is headquartered in Columbus, Georgia.
Amarin Corp PLC (NASDAQ:AMRN) - Amarin Corporation Plc, a clinical-stage biopharmaceutical company, focuses on developing treatments for cardiovascular diseases. The companys lead product candidate includes AMR101, a prescription grade Omega-3 product, which is in a second Phase III clinical trials for the treatment of patients on statin therapy with high triglycerides and mixed dyslipidemia. It also has next-generation lipid candidates under evaluation for preclinical development. The company, formerly known as Ethical Holdings plc, was founded in 1989 and is based in Dublin, Ireland.
Fossil Inc (NASDAQ:FOSL) - Fossil, Inc. designs, develops, markets, and distributes fashion accessories worldwide. It offers a line of fashion watches under its proprietary brands, such as FOSSIL, MICHELE, RELIC, and ZODIAC; and through licensed brands, including ADIDAS, BURBERRY, DIESEL, DKNY, EMPORIO ARMANI, MARC BY MARC JACOBS, and MICHAEL KORS. The company designs, markets, and arranges for the manufacture of watches and accessories on behalf of certain mass market retailers, companies, and organizations as private label products or as premium and incentive items for use in various corporate events. It also provides various fashion accessories for men and women, including handbags, belts, small leather goods, jewelry, and sunglasses through company owned retail stores, department stores, and specialty retail stores, as well as over the Internet and through catalogs. In addition, the company sells a line of soft accessories, such as hats, gloves, and scarves, as well as a handbag collection. Further, it offers apparel comprising jeans, outerwear, fashion tops and bottoms, and tee shirts for men and women through company-owned stores, as well as over the Internet and through catalogs. Additionally, the company provides footwear products, including sport court sneakers, authentic casuals, dress classics, and boots for men, as well as fashionable flats, heels, wedges, and boots for women. Fossil, Inc., through a license agreement with the Safilo Group, manufactures, markets, and sells optical frames under the FOSSIL and RELIC brand names in the United States and Canada. As of January 1, 2011, it operated 364 stores comprising 230 full price accessory stores; 93 outlet stores; 31 clothing stores; and 10 full price multi-brand stores. The company was founded in 1984 and is headquartered in Richardson, Texas.
SCHWAB (NYSE:SCHW) - The Charles Schwab Corporation, through its subsidiaries, provides securities brokerage, banking, and related financial services to individuals and institutional clients. The company offers various brokerage products and services comprising asset management accounts, including accounts with check-writing features, debit card, and billpay; individual retirement accounts; retirement plans for small to large businesses; 529 college savings accounts; separately managed accounts; designated brokerage accounts; equity incentive plan accounts; and margin loans, as well as access to fixed income securities, equity and debt offerings, and exchange traded funds. It also offers various banking products and services, including first mortgages, home equity lines of credit, pledged-asset loans, certificates of deposit, demand deposit accounts, checking accounts linked to brokerage accounts, savings accounts, and credit cards. In addition, the company provides trust custody services, personal trust reporting services, and administrative trustee services; and mutual funds, such as third-party mutual funds, no-load mutual funds, proprietary mutual funds, other third-party mutual funds, and mutual fund trading and clearing services to broker-dealers. Further, it provides research, analytic tools, performance reports, market analysis, and educational materials. Additionally, the company offers custodial, trading, technology, practice management, trust asset, and other support services to independent investment advisors; and retirement plan services, plan administrator services, and stock plan services. It operates primarily in the United States, the United Kingdom, and Hong Kong. The company was founded in 1971 and is headquartered in San Francisco, California.
INNOPHOS HOLDINGS INC (NASDAQ:IPHS) - Innophos Holdings, Inc., together with its subsidiaries, produces and sells specialty phosphates primarily in North America. The company offers specialty salts and specialty acids, such as sodium aluminum phosphate, sodium acid pyrophosphate, sodium hexametaphosphate, monocalcium phosphate, dicalcium phosphate, tricalcium phosphate, pharma calcium phosphate, ammonium phosphate, potassium phosphate, polyacid, and sodium tripolyphosphate. Its specialty salts are used as flavor enhancers in beverages, electrolytes in sports drinks, texture modifiers in cheeses, leavening agents in baked goods, calcium and phosphorus sources for nutritional supplements, and pharmaceutical excipients and abrasives in toothpastes; and specialty acids are used in industrial applications, such as asphalt modification and petrochemical catalysis. The company also provides purified phosphoric acid (PPA), which is used to manufacture specialty phosphate salts and acids, as well as used directly in beverage applications as a flavor enhancer, and in water treatment applications. In addition, it offers technical grade sodium tripolyphosphate that is used in cleaning products, including automatic dishwashing detergents, industrial and institutional cleaners, and consumer laundry detergents, as well as in water treatment, clay processing, and copper ore processing; and other products, such as phosphate fertilizers, which are co-products of manufacturing PPA. The companys customers include consumer goods manufacturers, distributors, and specialty chemical manufacturers in food, beverage, pharmaceutical, and cleaning product markets. Innophos Holdings, Inc. is headquartered in Cranbury, New Jersey.
TAPIMMUNE INC (OTCBB:TPIV) - TapImmune Inc., a biotechnology company, engages in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection. The company focuses on conducting studies using its transporters of antigen processing (TAP) gene technology in combination with an adeno virus. Its products include TAP cancer vaccine, which is under preclinical trial used for the treatment of breast cancer, prostate cancer, lung cancer, liver cancer, melanoma, renal cancer, and colorectal cancer. The company also develops therapeutics for infectious diseases using its TAP gene technology. TapImmune has strategic relationships with University of British Columbia, Crucell Holland B.V., Aeras Global TB Foundation, National Institute of Allergy and Infectious Diseases, and Mayo Clinic. The company was founded in 1999 and is based in Seattle, Washington.
About BUYINS.NET
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING
SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.
Contact:
BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net